Palliative Care

Global Palliative Care Market to Reach US$218.8 Billion by 2030

The global market for Palliative Care estimated at US$134.0 Billion in the year 2024, is expected to reach US$218.8 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Cancer, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$76.5 Billion by the end of the analysis period. Growth in the Dementia segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$36.5 Billion While China is Forecast to Grow at 13.7% CAGR

The Palliative Care market in the U.S. is estimated at US$36.5 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$48.5 Billion by the year 2030 trailing a CAGR of 13.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Palliative Care Market – Key Trends & Drivers Summarized

Why Is Palliative Care Becoming More Essential in Global Healthcare?

The demand for palliative care is increasing as the global population ages and the prevalence of chronic and life-limiting illnesses continues to rise. Palliative care plays a crucial role in improving the quality of life for patients with serious conditions such as cancer, cardiovascular diseases, neurodegenerative disorders, and advanced organ failure. As healthcare systems emphasize patient-centered care, the integration of palliative services into hospitals, hospices, and home-based settings has gained traction. Additionally, advancements in pain management, psychological support, and holistic therapies are enhancing the scope and accessibility of palliative care.

How Are Medical Innovations and Digital Health Transforming Palliative Care?

Technology is playing a key role in expanding access to palliative care services. The adoption of telemedicine, AI-driven symptom management, and remote patient monitoring has made palliative care more accessible, particularly in rural and underserved areas. Digital health platforms allow healthcare providers to coordinate patient care, offer virtual consultations, and optimize medication management. Additionally, the integration of wearable health devices enables real-time monitoring of vital signs, pain levels, and treatment effectiveness, allowing caregivers to provide timely interventions. The use of AI and predictive analytics is also helping healthcare professionals personalize treatment plans and anticipate patient needs more accurately.

What Challenges Exist in Expanding Palliative Care Services?

Despite its growing importance, palliative care faces challenges such as limited awareness, inadequate funding, and shortages of trained healthcare professionals. In many regions, palliative services are underdeveloped due to a lack of integration with primary healthcare systems and insufficient reimbursement policies. Additionally, cultural and social stigmas surrounding end-of-life care can prevent patients and families from seeking palliative services early in their disease progression. However, increasing advocacy efforts and policy reforms are gradually addressing these barriers, encouraging wider adoption of palliative care programs.

What’s Fueling the Growth of the Palliative Care Market?

The growth in the palliative care market is driven by several factors, including the rising incidence of chronic illnesses, increasing healthcare expenditures on supportive care, and the expansion of home-based palliative care services. The shift toward value-based healthcare models and patient-centered treatment approaches is further promoting the integration of palliative care into mainstream medical practice. Additionally, government initiatives and non-profit organizations focused on palliative care awareness, training, and funding are strengthening healthcare infrastructure to support this essential medical service.

SCOPE OF STUDY:

The report analyzes the Palliative Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Condition (Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease, Other Conditions); Diagnostic Group (Non Communicable Diseases Group, Communicable Diseases Group, Injury Poisoning & External Causes Group, Maternal Perinatal & Nutritional Conditions Group); Provider Type (Home Based Providers, Hospitals & Clinics, Community Settings)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -
  • African Palliative Care Association (APCA)
  • Asia Pacific Hospice Palliative Care Network (APHN)
  • Canadian Hospice Palliative Care Association (CHPCA)
  • Chinese Association for Life Care
  • European Association for Palliative Care (EAPC)
  • German Association for Palliative Medicine (DGP)
  • Hospice and Palliative Nurses Association (HPNA)
  • Hospice UK
  • Indian Association of Palliative Care (IAPC)
  • International Association for Hospice & Palliative Care (IAHPC)
  • Italian Society for Palliative Care (SICP)
  • Japanese Society for Palliative Medicine (JSPM)
  • Korean Society for Hospice and Palliative Care
  • Latin American Association for Palliative Care (ALCP)
  • National Hospice and Palliative Care Organization (NHPCO)
  • New Zealand Palliative Care Council
  • Palliative Care Australia
  • Palliative Care South Africa (PCSSA)
  • Singapore Hospice Council
  • Worldwide Hospice Palliative Care Alliance (WHPCA)

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Palliative Care – Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Geriatric Population and Chronic Disease Burden Throw Spotlight on Palliative Care Needs
Shift Toward Home-Based and Community Care Expands Access to Palliative Services
Integration of Pain Management and Psychosocial Support Enhances Care Continuum
Government and Insurance Support Strengthen Business Case for Palliative Reimbursement
Technological Advancements in Remote Monitoring Drive Adoption in Home Settings
Increased Awareness of End-of-Life Planning Spurs Demand for Specialized Care Programs
Multidisciplinary Care Models Sustain Growth Across Acute and Long-Term Care Facilities
Cultural Acceptance and Patient-Centered Care Trends Enhance Service Adoption
Training Programs and Workforce Development Initiatives Address Caregiver Shortages
Telehealth and Virtual Palliative Care Services Expand Reach in Underserved Areas
Hospice and Palliative Care Mergers Create Scalable Service Networks
Oncology and Neurology Referrals Propel Demand for Integrated Palliative Pathways
Value-Based Healthcare Policies Drive Investments in Palliative Quality Metrics
Pharmaceutical Innovation in Pain and Symptom Control Supports Clinical Outcomes
NGO and Philanthropic Funding Boosts Palliative Infrastructure in Low-Resource Regions
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Palliative Care Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Palliative Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Palliative Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Palliative Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Dementia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Dementia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Dementia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for HIV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for HIV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for HIV by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Cerebrovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Cerebrovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Cerebrovascular Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Respiratory Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Respiratory Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Respiratory Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Other Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Other Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Maternal Perinatal & Nutritional Conditions Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Maternal Perinatal & Nutritional Conditions Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Maternal Perinatal & Nutritional Conditions Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Non Communicable Diseases Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Non Communicable Diseases Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Non Communicable Diseases Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Communicable Diseases Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Communicable Diseases Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Communicable Diseases Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Injury Poisoning & External Causes Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Injury Poisoning & External Causes Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Injury Poisoning & External Causes Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Home Based Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Home Based Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for Home Based Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 39: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for Community Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 42: World Historic Review for Community Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: World 15-Year Perspective for Community Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 44: USA Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: USA Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: USA 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 47: USA Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: USA Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: USA 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: USA Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: USA 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
CANADA
TABLE 53: Canada Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: Canada 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 56: Canada Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Canada 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: Canada Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Canada 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
JAPAN
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 62: Japan Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Japan 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 65: Japan Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Japan Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: Japan 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 68: Japan Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: Japan 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
CHINA
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 71: China Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: China Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: China 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 74: China Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: China Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: China 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 77: China Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: China Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: China 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
EUROPE
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 80: Europe Recent Past, Current & Future Analysis for Palliative Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Palliative Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Europe 15-Year Perspective for Palliative Care by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Europe 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 86: Europe Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: Europe 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Europe Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: Europe 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
FRANCE
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 92: France Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: France Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: France 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 95: France Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: France Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: France 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 98: France Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: France Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: France 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
GERMANY
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 101: Germany Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Germany 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 104: Germany Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Germany Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Germany 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 107: Germany Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Germany Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Germany 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
ITALY
TABLE 110: Italy Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: Italy 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 113: Italy Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: Italy Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: Italy 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 116: Italy Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: Italy Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: Italy 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
UNITED KINGDOM
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 119: UK Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: UK Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: UK 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 122: UK Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: UK Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: UK 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 125: UK Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: UK Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: UK 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
SPAIN
TABLE 128: Spain Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: Spain Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: Spain 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 131: Spain Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Spain Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: Spain 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 134: Spain Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Spain Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: Spain 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
RUSSIA
TABLE 137: Russia Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Russia Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: Russia 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 140: Russia Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Russia Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: Russia 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 143: Russia Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Russia Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: Russia 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Rest of Europe Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: Rest of Europe 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: Rest of Europe Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 151: Rest of Europe 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Rest of Europe Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 154: Rest of Europe 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Palliative Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Palliative Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 157: Asia-Pacific 15-Year Perspective for Palliative Care by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 159: Asia-Pacific Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 160: Asia-Pacific 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: Asia-Pacific Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 163: Asia-Pacific 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Asia-Pacific Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 166: Asia-Pacific 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
AUSTRALIA
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 167: Australia Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Australia Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 169: Australia 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 170: Australia Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: Australia Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 172: Australia 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 173: Australia Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: Australia Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 175: Australia 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
INDIA
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 176: India Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: India Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 178: India 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 179: India Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: India Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 181: India 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 182: India Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: India Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 184: India 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 185: South Korea Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: South Korea Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 187: South Korea 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 188: South Korea Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: South Korea Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 190: South Korea 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 191: South Korea Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: South Korea Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 193: South Korea 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: Rest of Asia-Pacific Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: Rest of Asia-Pacific Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Rest of Asia-Pacific Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
LATIN AMERICA
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 203: Latin America Recent Past, Current & Future Analysis for Palliative Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Palliative Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 205: Latin America 15-Year Perspective for Palliative Care by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 206: Latin America Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 207: Latin America Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 208: Latin America 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 209: Latin America Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 210: Latin America Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 211: Latin America 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 212: Latin America Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 213: Latin America Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 214: Latin America 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 215: Argentina Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 216: Argentina Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 217: Argentina 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 218: Argentina Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 219: Argentina Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 220: Argentina 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 221: Argentina Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 222: Argentina Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 223: Argentina 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
BRAZIL
TABLE 224: Brazil Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 225: Brazil Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 226: Brazil 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 227: Brazil Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 228: Brazil Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 229: Brazil 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 230: Brazil Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 231: Brazil Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 232: Brazil 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
MEXICO
TABLE 233: Mexico Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 234: Mexico Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 235: Mexico 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 236: Mexico Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 237: Mexico Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 238: Mexico 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 239: Mexico Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 240: Mexico Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 241: Mexico 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 243: Rest of Latin America Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 244: Rest of Latin America 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 246: Rest of Latin America Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 247: Rest of Latin America 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 249: Rest of Latin America Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 250: Rest of Latin America 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
MIDDLE EAST
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 251: Middle East Recent Past, Current & Future Analysis for Palliative Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Palliative Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 253: Middle East 15-Year Perspective for Palliative Care by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 254: Middle East Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 255: Middle East Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 256: Middle East 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 257: Middle East Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 258: Middle East Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 259: Middle East 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 260: Middle East Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 261: Middle East Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 262: Middle East 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
IRAN
TABLE 263: Iran Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 264: Iran Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 265: Iran 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 266: Iran Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 267: Iran Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 268: Iran 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 269: Iran Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 270: Iran Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 271: Iran 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
ISRAEL
TABLE 272: Israel Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 273: Israel Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 274: Israel 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 275: Israel Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 276: Israel Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 277: Israel 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 278: Israel Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 279: Israel Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 280: Israel 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 282: Saudi Arabia Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 283: Saudi Arabia 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 285: Saudi Arabia Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 286: Saudi Arabia 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 288: Saudi Arabia Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 289: Saudi Arabia 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 290: UAE Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 291: UAE Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 292: UAE 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 293: UAE Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 294: UAE Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 295: UAE 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 296: UAE Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 297: UAE Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 298: UAE 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 300: Rest of Middle East Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 301: Rest of Middle East 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 303: Rest of Middle East Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 304: Rest of Middle East 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 306: Rest of Middle East Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 307: Rest of Middle East 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
AFRICA
Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 308: Africa Recent Past, Current & Future Analysis for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 309: Africa Historic Review for Palliative Care by Condition - Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 310: Africa 15-Year Perspective for Palliative Care by Condition - Percentage Breakdown of Value Sales for Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease and Other Conditions for the Years 2015, 2025 & 2030
TABLE 311: Africa Recent Past, Current & Future Analysis for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 312: Africa Historic Review for Palliative Care by Diagnostic Group - Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 313: Africa 15-Year Perspective for Palliative Care by Diagnostic Group - Percentage Breakdown of Value Sales for Maternal Perinatal & Nutritional Conditions Group, Non Communicable Diseases Group, Communicable Diseases Group and Injury Poisoning & External Causes Group for the Years 2015, 2025 & 2030
TABLE 314: Africa Recent Past, Current & Future Analysis for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 315: Africa Historic Review for Palliative Care by Provider Type - Home Based Providers, Hospitals & Clinics and Community Settings Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 316: Africa 15-Year Perspective for Palliative Care by Provider Type - Percentage Breakdown of Value Sales for Home Based Providers, Hospitals & Clinics and Community Settings for the Years 2015, 2025 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings